These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 22711276)

  • 1. Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.
    Zhao L; Chen CN; Hajji N; Oliver E; Cotroneo E; Wharton J; Wang D; Li M; McKinsey TA; Stenmark KR; Wilkins MR
    Circulation; 2012 Jul; 126(4):455-67. PubMed ID: 22711276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of valproic acid in a combined monocrotaline and chronic hypoxia rat model of severe pulmonary hypertension.
    Lan B; Hayama E; Kawaguchi N; Furutani Y; Nakanishi T
    PLoS One; 2015; 10(1):e0117211. PubMed ID: 25629315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to letter regarding article, “histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid”.
    Zhao L; Chen CN; Hajji N; Oliver E; Cotroneo E; Wharton J; Wilkins MR; Wang D; Li M; Stenmark KR; McKinsey TA; Buttrick P
    Circulation; 2013 Apr; 127(14):e540. PubMed ID: 23691553
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter by Bogaard et al regarding article, "histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid".
    Bogaard HJ; Mizuno S; Voelkel NF
    Circulation; 2013 Apr; 127(14):e539. PubMed ID: 23569123
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism.
    Cavasin MA; Demos-Davies K; Horn TR; Walker LA; Lemon DD; Birdsey N; Weiser-Evans MC; Harral J; Irwin DC; Anwar A; Yeager ME; Li M; Watson PA; Nemenoff RA; Buttrick PM; Stenmark KR; McKinsey TA
    Circ Res; 2012 Mar; 110(5):739-48. PubMed ID: 22282194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary artery smooth muscle cell proliferation and migration in fetal lambs acclimatized to high-altitude long-term hypoxia: role of histone acetylation.
    Yang Q; Lu Z; Ramchandran R; Longo LD; Raj JU
    Am J Physiol Lung Cell Mol Physiol; 2012 Dec; 303(11):L1001-10. PubMed ID: 23043075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats.
    Bogaard HJ; Mizuno S; Hussaini AA; Toldo S; Abbate A; Kraskauskas D; Kasper M; Natarajan R; Voelkel NF
    Am J Respir Crit Care Med; 2011 May; 183(10):1402-10. PubMed ID: 21297075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration.
    Galletti M; Cantoni S; Zambelli F; Valente S; Palazzini M; Manes A; Pasquinelli G; Mai A; Galiè N; Ventura C
    Biochem Pharmacol; 2014 Sep; 91(2):181-90. PubMed ID: 25063234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension.
    Kim J; Hwangbo C; Hu X; Kang Y; Papangeli I; Mehrotra D; Park H; Ju H; McLean DL; Comhair SA; Erzurum SC; Chun HJ
    Circulation; 2015 Jan; 131(2):190-9. PubMed ID: 25336633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
    Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-1 signaling in neonatal hypoxia-induced pulmonary hypertension: Role of epigenetic regulation.
    Yang Q; Sun M; Ramchandran R; Raj JU
    Vascul Pharmacol; 2015 Oct; 73():20-31. PubMed ID: 25921925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
    Beyer M; Kiweler N; Mahboobi S; Krämer OH
    Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Requirements of Histone Deacetylase Inhibitors: SAHA Analogs Modified on the Hydroxamic Acid.
    Bieliauskas AV; Weerasinghe SV; Negmeldin AT; Pflum MK
    Arch Pharm (Weinheim); 2016 May; 349(5):373-82. PubMed ID: 27062198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo.
    Singh T; Prasad R; Katiyar SK
    Epigenetics; 2013 Jan; 8(1):54-65. PubMed ID: 23221619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of histone deacetylases in regulation of phenotype of ovine newborn pulmonary arterial smooth muscle cells.
    Yang Q; Dahl MJ; Albertine KH; Ramchandran R; Sun M; Raj JU
    Cell Prolif; 2013 Dec; 46(6):654-64. PubMed ID: 24460719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of histone deacetylases protects septic mice from lung and splenic apoptosis.
    Takebe M; Oishi H; Taguchi K; Aoki Y; Takashina M; Tomita K; Yokoo H; Takano Y; Yamazaki M; Hattori Y
    J Surg Res; 2014 Apr; 187(2):559-70. PubMed ID: 24290430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors selectively suppress expression of HDAC7.
    Dokmanovic M; Perez G; Xu W; Ngo L; Clarke C; Parmigiani RB; Marks PA
    Mol Cancer Ther; 2007 Sep; 6(9):2525-34. PubMed ID: 17876049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009.
    Hsieh IN; Liou JP; Lee HY; Lai MJ; Li YH; Yang CR
    Cell Death Dis; 2014 Apr; 5(4):e1166. PubMed ID: 24722291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibition by suberoylanilide hydroxamic acid: a therapeutic approach to treat human uterine leiomyoma.
    Carbajo-García MC; García-Alcázar Z; Corachán A; Monleón J; Trelis A; Faus A; Pellicer A; Ferrero H
    Fertil Steril; 2022 Feb; 117(2):433-443. PubMed ID: 34809976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.
    Lunke S; Maxwell S; Khurana I; K N H; Okabe J; Al-Hasani K; El-Osta A
    Clin Epigenetics; 2021 Mar; 13(1):58. PubMed ID: 33743782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.